Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Operating Expenses | 40,682 | 32,062 | 25,223 | 3,233 | 83,951 |
| Operating Income | -40,682 | -32,062 | -25,223 | -3,233 | -83,951 |
| Interest Expense | 0 | 0 | 1,213 | 3,612 | 2,210 |
| Other Income | 7,671 | 908 | 48 | 0 | 0 |
| Pre-tax Income | -33,011 | -31,154 | -26,388 | -6,845 | -86,161 |
| Net Income Continuous | -33,011 | -31,154 | -26,388 | -6,845 | -86,161 |
| Net Income | $-32,811 | $-31,154 | $-26,388 | $-6,845 | $-86,161 |
| EPS Basic Total Ops | -2.22 | -2.54 | -5.07 | -40.03 | -30.42 |
| EPS Basic Continuous Ops | -2.23 | -2.54 | -5.07 | -40.03 | -30.59 |
| EPS Diluted Total Ops | -2.22 | -2.54 | -5.07 | -40.03 | -30.42 |
| EPS Diluted Continuous Ops | -2.23 | -2.54 | -5.07 | -40.03 | -30.59 |
| EPS Diluted Before Non-Recurring Items | -2.22 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-40,586 | $-31,985 | $-25,223 | $-3,233 | $-83,278 |